| title: |
| Data set for “Safety of Biologics for the treatment of Asthma in children and adolescents:
a systematic review”: [research data] |
|
| contributing persons: |
| Manfred Ballmann[VerfasserIn] |
 |
0000-0003-4480-1312 |
 |
115461922 |
|
Rostock University Medical Center, Department of Pediatrics |
| Elisa Wirthgen[VerfasserIn] |
|
0000-0002-8696-1675 |
|
1028065590 |
|
Rostock University Medical Center |
| Susann Quickert[VerfasserIn] |
|
Rostock University Medical Center |
| Julia Weitzel[VerfasserIn] |
|
Rostock University Medical Center |
| Birgit Salewski[VerfasserIn] |
|
Rostock University Medical Center |
|
| |
| abstract: |
|
Our systematic literature search provides no new, unexpected or unique safety profile
for biologics used in asthma therapy in children and adolescents compared to descriptions
of the respective product labels. Many common AEs occurred across both short-term
and long-term studies. These AEs were expected and in line with prior safety information
on these drugs. However, the long-term safety of biologics, particularly that of rare
or serious conditions, still requires careful monitoring.
[English] |
|
| document type: |
|
| institution: |
|
| language: |
|
| subject class (DDC): |
| 610 Medical sciences Medicine |
|
| |
publication /
production: |
Rostock
|
Rostock: University of Rostock
|
|
2025
|
|
| statement of responsibility: |
| Elisa Wirthgen; Susann Quickert; Julia Weitzel; Birgit Salewski; Manfred Ballmann |
|
| |
| identifiers: |
|
| references: |
Forschungsdaten zu:
Wirthgen E, Quickert S, Weitzel J, et al. Safety of biologics for the treatment of
asthma in children and adolescents: a systematic review. Eur Respir Rev 2025; 0:240269.
|
|
| |
| access condition: |
|
| license/rights statement: |
|
|
| RosDok id: |
rosdok_document_0000025749 |
| created / modified: |
10.07.2024 / 15.05.2025
|
| metadata license: |
The metadata of this document was dedicated to the public domain
(CC0 1.0 Universal Public Domain Dedication). |
access
